COMMONWEALTH BANK OF AUSTRALIA (CBA)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

CBA

CBA - COMMONWEALTH BANK OF AUSTRALIA

FNArena Sector : Banks
Year End: June
GICS Industry Group : Banks
Debt/EBITDA: N/A
Index: ASX20 | ASX50 | ASX100 | ASX200 | ASX300 | ALL-ORDS

Commonwealth Bank is Australia's largest retail bank with a market cap of over $122bn. It provides a range of financial services, including retail, business and institutional banking, plus broking facilities through CommSec. CBA was first listed in September 1991.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$150.04

27 Mar
2025

-0.190

OPEN

$149.23

-0.13%

HIGH

$150.04

1,665,426

LOW

$148.38

TARGET
$107.458 -28.4% downside
Franking for last dividend paid out: 100%
OTHER COMPANIES IN THE SAME SECTOR
AFG . ANZ . BEN . BOQ . HLI . MYS . NAB . RMC . SUN . WBC .
FNARENA'S MARKET CONSENSUS FORECASTS
CBA: 1
Title FY23
Actual		 FY24
Actual		 FY25
Forecast		 FY26
Forecast
EPS (cps) xxx 567.4 609.5 xxx
DPS (cps) xxx 465.0 479.8 xxx
EPS Growth xxx - 6.1% 7.4% xxx
DPS Growth xxx 3.3% 3.2% xxx
PE Ratio xxx N/A 24.7 xxx
Dividend Yield xxx N/A 3.2% xxx
Div Pay Ratio(%) xxx 82.0% 78.7% xxx

Dividend yield today if purchased 3 years ago: 4.37%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 3.09

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 21/08 - ex-div 250c (franking 100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2025 FactSet UK Limited. All rights reserved
Title 201920202021202220232024
EPS Basic 485.6544.9574.9625.5603.9567.4
DPS All 431.0298.0350.0385.0450.0465.0
Sales/Revenue 41,155.0 M35,793.0 M30,201.0 M29,201.0 M49,096.0 M65,724.0 M
Book Value Per Share 3,936.94,072.54,441.04,284.54,299.74,371.1
Net Operating Cash Flow 11,527.0 M1,247.0 M13,305.0 M21,660.0 M8,347.0 M8,914.0 M
Net Profit Margin 20.31 %20.84 %29.28 %33.13 %20.75 %14.43 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201920202021202220232024
Return on Capital Employed 12.21 %10.54 %11.73 %12.77 %14.07 %13.07 %
Return on Invested Capital 3.69 %3.28 %4.12 %4.68 %4.63 %4.10 %
Return on Assets 0.86 %0.75 %0.84 %0.84 %0.83 %0.76 %
Return on Equity 12.21 %10.54 %11.73 %12.77 %14.07 %13.07 %
Return on Total Capital 3.88 %3.58 %4.55 %5.22 %4.82 %4.23 %
Free Cash Flow ex dividends 4,348.0 M-7,292.0 M8,938.0 M14,894.0 M547.0 M890.0 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201920202021202220232024
Short-Term Debt 69,194 M53,283 M42,088 M50,973 M109,521 M89,686 M
Long Term Debt 160,231 M152,995 M125,141 M137,025 M158,034 M159,661 M
Total Debt 229,425 M206,278 M167,229 M187,998 M267,555 M249,347 M
Goodwill - Gross 5,974 M5,284 M5,317 M5,295 M5,295 M5,285 M
Cash & Equivalents - Generic 16,655 M27,307 M87,375 M119,355 M107,172 M47,321 M
Price To Book Value 2.101.702.252.112.332.91

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201920202021202220232024
Capex 640.0 M1,592.0 M767.0 M977.0 M1,568.0 M1,322.0 M
Capex % of Sales 1.56 %4.45 %2.54 %3.35 %3.19 %2.01 %
Cost of Goods Sold ------
Selling, General & Admin. Exp & Other 4,687 M4,500 M4,565 M4,194 M4,081 M3,938 M
Research & Development ------
Investments - Total 157,891 M178,410 M161,923 M185,153 M187,123 M230,863 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

-1.0

No. Of Recommendations

6
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Morgan Stanley

xx/xx/xxxx

5

xxxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgans

xx/xx/xxxx

5

xxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Citi

xx/xx/xxxx

5

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

13/02/2025

5

Sell

$115.00

-23.35%

UBS retains its $115 target for CommBank following 1H results. The Sell rating is also maintained on valuation, with the analyst highlighting an around 40% share price rise over the past 12-months.

A summary of yesterday's research by the broker follows.

UBS is yet another broker to question CommBank's valuation in light of a 60c EPS beat for 1H25. The broker highlights a 40% rise in the share price for a 3.2% lift in the 1H25 EPS result over the last year.

On first inspection, the analyst notes revenue growth of 4% was in line with expectations, while opex was higher than anticipated, up 3% on the previous half-year. Impairment expenses were lower than forecast by -18% and -27% below consensus.

While UBS believes the results are positive in terms of factors underpinning EPS momentum, the analyst raises a flag over cost growth.

The dividend met expectations.

FORECAST
UBS forecasts a full year FY25 dividend of 474.00 cents and EPS of 614.00 cents.
UBS forecasts a full year FY26 dividend of 483.00 cents and EPS of 641.00 cents.

Macquarie

xx/xx/xxxx

5

xxxxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Ord Minnett

xx/xx/xxxx

5

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial
Access Stockbroker Research History >
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

2

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Jarden

xx/xx/xxxx

5

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Goldman Sachs

16/10/2024

-1

No Rating

-

As a result of analyst Andrew Lyons leaving the employ of Goldman Sachs, the broker is suspending research coverage of CommBank.

The former rating, target, and forecasts no longer apply.
Access Extra Coverage Research History >

CBA STOCK CHART

FNArena News on CBA

1
Next Week At A Glance – 31 Mar – 4 April, 2025

Mar 28 2025 - Weekly Reports
2
Australian Broker Call *Extra* Edition – Mar 27, 2025

Mar 27 2025 - Daily Market Reports
3
Clouds Are Gathering For Aussie Banks

Mar 27 2025 - Australia
4
Weekly Ratings, Targets, Forecast Changes – 21-03-25

Mar 24 2025 - Weekly Reports
5
Next Week At A Glance 24-28 Mar 2025

Mar 21 2025 - Weekly Reports

Latest Banks News

1
Clouds Are Gathering For Aussie Banks

Mar 27 2025 - Australia
2
Australian Banks: More De-Rating Ahead?

Mar 11 2025 - Australia
3
Higher Highs Beckon For CommBank Shares

Feb 11 2025 - Technicals
4
ANZ Bank Shares Look Poised

Oct 29 2024 - Technicals
5
Australian Banks: When The End Of The Trend?

Oct 07 2024 - Feature Stories
6
CBA Shares Find Technical Support

Oct 01 2024 - Technicals
7
June In Review: FY24 Another Double Digit Return

Jul 03 2024 - Australia
8
In Brief: Gas, Gold, Groceries & Aussie Banks

Jun 07 2024 - Weekly Reports
9
Better Value In Smaller Banks?

Jun 03 2024 - Small Caps
10
Australian Banks Post First Half Results: Sugar Hit

May 23 2024 - Feature Stories